← SynDRA
TOLOXATONE
SynDRA canonical compound SYN0001049 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Primary target(s) | MAOA | MAOB |
|---|
| Mechanism of action | monoamine oxidase inhibitor |
|---|
| Indication | depression |
|---|
| Disease area | neurology/psychiatry |
|---|
All known targets
Mechanisms of action (all sources)
- MAOA INHIBITOR
- Monoamine oxidase A inhibitor
- monoamine oxidase inhibitor
- MAOB INHIBITOR
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- ADORA1
- HDAC6
- HRH2
- HRH3
- HTR1A
- HTR2A
- HTR2B
- HTR2C
- HTR3A
- KCNH2
- MC3R
- MLNR
- NPY1R
- NR1I2
- NR3C1
- OPRK1
- OPRM1
- PDE3A
- PDE4D
- PGR
- PTGS2
- SLC6A3
- SLC6A4
- HRH1
- GHSR
- ADORA2A
- FAAH
- ADORA3
- ADRA1A
- ADRA2A
- ADRA2B
- ADRA2C
- ADRB1
- AGTR1
- AVPR1A
- AVPR2
- BDKRB2
- CCKAR
- CCKBR
- CHRM1
Drug classes
- Antidepressive Agents
- Central Nervous System Agents
- Enzyme Inhibitors
- Monoamine Oxidase Inhibitors
- Psychotropic Drugs
ATC classes
Cross-references
Synonyms
- humoryl
- taloxotone
- Toloxatona
- Humoryl
- Perenum
- 5-(Hydroxymethyl)-3-(m-tolyl)oxazolidin-2-one
- Toloxatone [INN]
- Delalande 69276
- Toloxatonum [INN-Latin]
- Toloxatona [INN-Spanish]
- 5-(Hydroxymethyl)-3-(3-methylphenyl)-2-oxazolidinone
- EINECS 249-522-2
- BRN 0527506
- 69276 MD
- CHEMBL18116
- 2-oxazolidinone, 5-(hydroxymethyl)-3-(3-methylphenyl)-
- 5-Hydroxymethyl-3-(m-tolyl)-2-oxazolidinone
- 5-(Hydroxymethyl)-3-m-tolyl-2-oxazolidinone
- Toloxatone (INN)
- 5-(hydroxymethyl)-3-m-tolyloxazolidin-2-one
- 2-Oxazolidinone, 5-hydroxymethyl-3-(m-t
- Toloxatonum
- Taloxotone
- 5T206015T5
- MD 69276
- (3-methyl)-3-phenyl-5-hydroxymethyl-2-oxazolidinone
- RefChem:898548
- DTXCID10813880
- N06AG03
- CHEBI:134870
- 5-(hydroxymethyl)-3-(3-methylphenyl)-1,3-oxazolidin-2-one
- MFCD00865391
- Umoril
- MXUNKHLAEDCYJL-UHFFFAOYSA-N
- UNII-5T206015T5
- Humoryl (TN)
- TOLOXATONE [MI]
Look up TOLOXATONE in the interactive SynDRA portal →